Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-02-02 Sale |
2024-02-05 7:54 pm |
Arbutus Biopharma Corp | ABUS | Sofia Michael J. Chief Scientific Officer |
9,982 | $2.3125 | $23,083 | 2,090,083 (Indirect Direct) |
View |
| 2021-12-01 Sale |
2021-12-03 4:02 pm |
Arbutus Biopharma Corp | ABUS | Sofia Michael J. Chief Scientific Officer |
200,000 | $5.09 | $1,018,000 | 1,470,565 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-02-01 Option Award |
2024-02-05 7:54 pm |
N/A 2034-02-01 |
Arbutus Biopharma Corp | ABUS | Sofia Michael J. Chief Scientific Officer |
547,300 | $0 | 2,090,083 (Direct) |
View |
| 2023-02-01 Option Award |
2023-02-03 4:11 pm |
N/A 2033-02-01 |
Arbutus Biopharma Corp | ABUS | Sofia Michael J. Chief Scientific Officer |
410,900 | $0 | 1,881,465 (Direct) |
View |
| 2022-01-20 Option Award |
2022-01-20 5:54 pm |
N/A 2032-01-20 |
Arbutus Biopharma Corp | ABUS | Sofia Michael J. Chief Scientific Officer |
285,000 | $2.81 | 285,000 (Direct) |
View |
| 2021-02-13 Option Award |
2021-02-17 4:52 pm |
N/A 2031-02-13 |
Arbutus Biopharma Corp | ABUS | Sofia Michael J. Chief Scientific Officer |
290,000 | $0 | 290,000 (Direct) |
View |